$$$ - Page 2035

Cognivia Advances Personalized Medicine with Strategic Investments

Cognivia Advances Personalized Medicine with Strategic Investments

Innovating the Clinical Trial Landscape with AI-Powered Patient Analysis Cognivia, an AI company at the forefront of pharmaceutical and biotech clinical research, proudly announces a significant milestone in receiving strategic investments. With the support of Vesalius Biocapital IV, Société Fédérale de Participations
April 18, 2024
Privacy policy
Contact